Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,037,483
  • Shares Outstanding, K 104,259
  • Annual Sales, $ 138,290 K
  • Annual Income, $ -140,850 K
  • 60-Month Beta 1.29
  • Price/Sales 52.54
  • Price/Cash Flow N/A
  • Price/Book 17.77
Trade ARWR with:

Options Overview Details

View History
  • Implied Volatility 61.77%
  • Historical Volatility 68.00%
  • IV Percentile 14%
  • IV Rank 32.00%
  • IV High 89.55% on 03/05/21
  • IV Low 48.70% on 10/20/21
  • Put/Call Vol Ratio 1.18
  • Today's Volume 367
  • Volume Avg (30-Day) 1,021
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 12,066
  • Open Int (30-Day) 17,216

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.37
  • Number of Estimates 3
  • High Estimate -0.05
  • Low Estimate -0.60
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -85.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.11 +6.96%
on 11/17/21
84.83 -20.43%
on 11/09/21
-12.93 (-16.08%)
since 11/03/21
3-Month
57.94 +16.50%
on 10/06/21
84.83 -20.43%
on 11/09/21
-0.05 (-0.07%)
since 09/03/21
52-Week
57.92 +16.54%
on 08/11/21
93.66 -27.93%
on 06/23/21
+3.52 (+5.50%)
since 12/03/20

Most Recent Stories

More News
Arrowhead Pharmaceuticals to Participate in Upcoming December 2021 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 67.50 (-3.14%)
Arrowhead Pharmaceuticals Reports Fiscal 2021 Year End Results

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal year ended September 30, 2021. The company is hosting a conference call today, November 22, 2021, at 4:30...

ARWR : 67.50 (-3.14%)
Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it entered into an exclusive license agreement with GlaxoSmithKline (LSE/NYSE: GSK) under which GSK will develop and commercialize ARO-HSD,...

ARWR : 67.50 (-3.14%)
Arrowhead Announces JNJ-75220795 in Development for NASH

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that its collaborator, Janssen Pharmaceuticals, Inc., (Janssen) one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has disclosed...

ARWR : 67.50 (-3.14%)
Arrowhead Collaborator Presents Phase 2b Clinical Data from REEF-1 Study in Patients with Chronic Hepatitis B Infection

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) collaborator Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, presented clinical data from REEF-1, a Phase...

ARWR : 67.50 (-3.14%)
Arrowhead Presents New Clinical Data on ARO-APOC3 at AHA 2021

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced additional Phase 1/2 clinical data on ARO-APOC3, the company’s investigational RNA interference (RNAi) therapeutic targeting apolipoprotein...

ARWR : 67.50 (-3.14%)
Arrowhead Presents Additional Clinical Data on Investigational ARO-HSD Treatment at AASLD Liver Meeting

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced additional interim clinical data from AROHSD1001, an ongoing Phase 1/2 clinical study of ARO-HSD, the company’s investigational RNA interference...

ARWR : 67.50 (-3.14%)
Arrowhead Presents Additional Clinical Data on Investigational ARO-AAT Treatment at AASLD Liver Meeting

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced additional interim clinical data from the ongoing AROAAT2002 study, an open-label Phase 2 clinical study of ARO-AAT, also known as TAK-999,...

ARWR : 67.50 (-3.14%)
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Year End Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on November 22, 2021, at 4:30 p.m. ET to discuss its financial results for the fiscal year...

ARWR : 67.50 (-3.14%)
Arrowhead Pharmaceuticals to Participate in Upcoming November 2021 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 67.50 (-3.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

3rd Resistance Point 73.32
2nd Resistance Point 71.86
1st Resistance Point 69.68
Last Price 67.50
1st Support Level 66.04
2nd Support Level 64.59
3rd Support Level 62.41

See More

52-Week High 93.66
Fibonacci 61.8% 80.01
Fibonacci 50% 75.79
Fibonacci 38.2% 71.57
Last Price 67.50
52-Week Low 57.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar